首页|丁苯酞对急性脑梗死合并脑白质疏松症患者认知功能的影响

丁苯酞对急性脑梗死合并脑白质疏松症患者认知功能的影响

扫码查看
目的 研究丁苯酞对急性脑梗死合并脑白质疏松症患者的认知功能的影响.方法 选择2014年6月~2015年6月在运城市中心医院诊治的急性脑梗死合并脑白质疏松症患者80例,且均有认知功能障碍,按照数字表法随机分为研究组和对照组,每组各40例.2组均给予脑梗死常规治疗,研究组加丁苯酞软胶囊2粒,3次/天口服,连续治疗3个月,于治疗后4w、8w、12w运用简易智力状态量表(mini-mental sate examination,MMSE)及蒙特利尔认知评估量表(Montreal cognitive assessment,MoCA)评定2组患者认知状况.分析研究组患者在治疗过程中肝功能的变化情况.结果 治疗中,2组患者的MMSE评分均有所改善,在治疗4w时研究组MMSE评分高于对照组,但是2组间比较差异无统计学意义,8w、12w时研究组MMSE评分明显高于对照组,且各组间比较差异有统计学意义(P<0.05);研究组患者MOCA评分逐渐趋于正常,且明显高于对照组,治疗后4w、8w、12w时各组间比较差异均有统计学意义(P<0.05);研究组患者在治疗中出现一过性肝功能异常,停药后恢复正常.结论 丁苯肽能明显改善急性脑梗死合并脑白质疏松患者的认知功能,治疗中引起的转氨酶升高,对临床用药无明显影响.
Effects of butyphthalide on cognitive function with acute cerebral infarction complicated with leukoaraiosis
Objective To study butylphthalide on acute cerebral infarction with leukoaraiosis patients cognitive function. Methods 80 patients with acute cerebral infarction combined with leukoaraiosis in Yuncheng Central Hospital from June 2014 to June 2015 were selected, all patients had cognitive dysfunction, and randomly divided into study group and control group with 40 cases in each group. The two groups were given conventional treatment of cerebral infarction, the study group was given the butylphthalide soft capsules two tablets, three times once day orally for three months, we used MMSE and MoCA scale to assess the cognitive status of the patients in the two groups at four, eight, and 12 weeks after treatment. The changes of liver function during treatment were analyzed. Results In the treatment, the two groups of patients with MMSE were improved, in four weeks of treatment, the MMSE scores of the study group was higher than the control group, but there was no significant difference between the two groups, eight weeks and 12 weeks, the MMSE scores of the study group was significantly higher than the control group, and the difference between the two groups was statistically significant (P<0.05), the MOCA score of patients in the study group gradually become normal, and significantly higher than the control group, after treatment for four weeks, eight weeks and 12 weeks the difference was statistically significant (P<0.05), the study group patients first had abnormal liver function in the treatment, recovered after stopping the medication. Conclusion Butylphthalide can improve the cognitive function of patients with acute cerebral infarction combined with leukoaraiosis, the increase of transaminase caused by treatment has no significant effect on clinical medication, which is worthy of further popularization and application.

butyphthalideacute cerebral infarctionleukoaraiosiscognitive function

费敏、柴常运、王飞

展开 >

山西省运城市中心医院 神经内科,山西 运城 044000

丁苯酞 急性脑梗死 脑白质疏松症 认知功能

2017

中国生化药物杂志
南京生物化学制药研究所,全国生化制药情报中心站,中国生化制药工业协会,中国药品生物制品检定所

中国生化药物杂志

ISSN:1005-1678
年,卷(期):2017.37(1)
  • 15
  • 17